Enzo Biochem Inc ENZ
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if ENZ is a good fit for your portfolio.
News
Trading Information
- Previous Close Price
- $1.14
- Day Range
- $1.12–1.16
- 52-Week Range
- $0.99–1.71
- Bid/Ask
- $1.03 / $1.20
- Market Cap
- $59.18 Mil
- Volume/Avg
- 53,740 / 124,736
Key Statistics
- Price/Earnings (Normalized)
- 7.07
- Price/Sales
- 2.36
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Enzo Biochem Inc is a bioscience company. The firm manufactures, develops and sell their proprietary solutions and platforms to clinical laboratories, specialty clinics and researchers and physicians internationally. It focuses on delivering and applying its technology to produce products and services to allow its customers to meet their clinical needs. The company has Enzo clinical labs, Enzo life sciences, Enzo therapeutics operating segments. It derives the majority of its revenues from the Clinical lab's segment.
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Stock Style Box
- Small Core
- Total Number of Employees
- 190
- Website
- https://www.enzo.com
Comparables
Valuation
|
Metric
|
ENZ
|
TIHE
|
TXG
|
|---|---|---|---|
Price/Earnings (Normalized) | 7.07 | — | — |
Price/Book Value | 0.85 | — | 3.37 |
Price/Sales | 2.36 | — | 3.82 |
Price/Cash Flow | — | — | — |
Price/Earnings
ENZ
TIHE
TXG
Financial Strength
|
Metric
|
ENZ
|
TIHE
|
TXG
|
|---|---|---|---|
Quick Ratio | 2.82 | — | 4.26 |
Current Ratio | 3.50 | — | 5.22 |
Interest Coverage | — | — | −18,311.33 |
Quick Ratio
ENZ
TIHE
TXG
Profitability
|
Metric
|
ENZ
|
TIHE
|
TXG
|
|---|---|---|---|
Return on Assets (Normalized) | −13.10% | — | −13.16% |
Return on Equity (Normalized) | −20.72% | — | −16.76% |
Return on Invested Capital (Normalized) | −19.74% | — | −16.49% |
Return on Assets
ENZ
TIHE
TXG
Diagnostics & Research Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Thermo Fisher Scientific Inc
TMO
| Shrwsvgvh | Zfvh | $226.9 Bil | |||
| Danaher Corp
DHR
| Bpzxcvhhv | Qwpjtmp | $197.8 Bil | |||
| IQVIA Holdings Inc
IQV
| Dkpythz | Zrrfnd | $43.7 Bil | |||
| Agilent Technologies Inc
A
| Lktcrfcyt | Kpsdm | $39.4 Bil | |||
| IDEXX Laboratories Inc
IDXX
| Ftcygqpdcs | Nwdfby | $38.8 Bil | |||
| Mettler-Toledo International Inc
MTD
| Pczhrkmrgz | Zpgcgx | $30.1 Bil | |||
| Icon PLC
ICLR
| Kvcdzlxw | Phjydk | $25.9 Bil | |||
| Illumina Inc
ILMN
| Mbpwdpzx | Qqrvpf | $18.7 Bil | |||
| Waters Corp
WAT
| Dtzbrtnzkk | Szn | $18.4 Bil | |||
| Labcorp Holdings Inc
LH
| Wrhfhxzh | Ftrcpg | $17.7 Bil |